{"pmid":32445955,"title":"Letter to the Editor in response to the article \"Could IL-17 represent a new therapeutic target for the treatment and/or management of COVID-19-related respiratory syndrome?\"","text":["Letter to the Editor in response to the article \"Could IL-17 represent a new therapeutic target for the treatment and/or management of COVID-19-related respiratory syndrome?\"","Pharmacol Res","Ceccarelli, Gabriele","Nardi, Katiuscia","Marchesani, Francesca","32445955"],"journal":"Pharmacol Res","authors":["Ceccarelli, Gabriele","Nardi, Katiuscia","Marchesani, Francesca"],"date":"2020-05-24T11:00:00Z","year":2020,"_id":"32445955","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1016/j.phrs.2020.104933","weight":0,"_version_":1667600475920269312,"score":9.490897,"similar":[{"pmid":32302707,"pmcid":"PMC7194796","title":"Could IL-17 represent a new therapeutic target for the treatment and/or management of COVID-19-related respiratory syndrome?","text":["Could IL-17 represent a new therapeutic target for the treatment and/or management of COVID-19-related respiratory syndrome?","Pharmacol Res","Casillo, Gian Marco","Mansour, Adel Abo","Raucci, Federica","Saviano, Anella","Mascolo, Nicola","Iqbal, Asif Jilani","Maione, Francesco","32302707"],"journal":"Pharmacol Res","authors":["Casillo, Gian Marco","Mansour, Adel Abo","Raucci, Federica","Saviano, Anella","Mascolo, Nicola","Iqbal, Asif Jilani","Maione, Francesco"],"date":"2020-04-18T11:00:00Z","year":2020,"_id":"32302707","source":"PubMed","week":"202016|Apr 13 - Apr 19","doi":"10.1016/j.phrs.2020.104791","topics":["Treatment","Mechanism"],"weight":1,"_version_":1666138494810980352,"score":69.026085}]}